Deep Track Capital, LP
- SEC CIK
- 0001856083
- 最新申報
- 2026/8/14
2026 年第 2 季持倉
持倉截至 2026/6/30，2026/8/14 申報。只含多頭部位，變化是跟 2026 年第 1 季比股數。
- 持股檔數
- 66
- 較 2026 年第 1 季 +4
- 總值
- $67.9 億
- 較 2026 年第 1 季 +$19.4 億 (+40.1%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| GHGuardant Health, Inc. | COM | 3,393,312 | $5.09 億 | 7.5% | +55,071+1.6% | 加碼 | 歷史 |
| IMVTImmunovant, Inc. | COM | 9,341,151 | $3.60 億 | 5.3% | −2,185,820−19.0% | 減碼 | 歷史 |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 4,740,072 | $2.54 億 | 3.7% | +460,224+10.8% | 加碼 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 4,300,000 | $2.50 億 | 3.7% | 00.0% | 不變 | 歷史 |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 825,000 | $2.48 億 | 3.7% | +825,000 | 新進 | 歷史 |
| MANEVeradermics, Inc | COMMON STOCK | 2,000,000 | $2.46 億 | 3.6% | +1,500,000+300.0% | 加碼 | 歷史 |
| TARSTarsus Pharmaceuticals, Inc. | COM | 3,666,768 | $2.31 億 | 3.4% | +66,768+1.9% | 加碼 | 歷史 |
| NUVLNuvalent, Inc. | COM | 1,783,322 | $2.20 億 | 3.2% | +406,998+29.6% | 加碼 | 歷史 |
| ALKSAlkermes plc. | SHS | 4,000,000 | $2.10 億 | 3.1% | +409,677+11.4% | 加碼 | 歷史 |
| OCULOcular Therapeutix, Inc | COM | 19,686,282 | $1.93 億 | 2.8% | 00.0% | 不變 | 歷史 |
| BMRNBiomarin Pharmaceutical Inc | COM | 3,307,481 | $1.89 億 | 2.8% | +2,157,481+187.6% | 加碼 | 歷史 |
| NRIXNurix Therapeutics, Inc. | COM | 7,736,455 | $1.88 億 | 2.8% | +1,391,211+21.9% | 加碼 | 歷史 |
| ORKAOruka Therapeutics, Inc. | COM | 1,926,000 | $1.83 億 | 2.7% | −108,203−5.3% | 減碼 | 歷史 |
| ALMSAlumis Inc. | COM | 6,348,558 | $1.79 億 | 2.6% | −424,037−6.3% | 減碼 | 歷史 |
| IONSIonis Pharmaceuticals Inc | COM | 2,200,000 | $1.74 億 | 2.6% | +250,000+12.8% | 加碼 | 歷史 |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 12,161,496 | $1.72 億 | 2.5% | 00.0% | 不變 | 歷史 |
| VERAVera Therapeutics, Inc. | CL A | 4,000,000 | $1.72 億 | 2.5% | −106,067−2.6% | 減碼 | 歷史 |
| AXSMAxsome Therapeutics, Inc. | COM | 700,000 | $1.71 億 | 2.5% | −400,000−36.4% | 減碼 | 歷史 |
| GMABGenmab A/S | SPONSORED ADS | 5,650,000 | $1.55 億 | 2.3% | +1,986,750+54.2% | 加碼 | 歷史 |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 6,999,025 | $1.36 億 | 2.0% | +590,162+9.2% | 加碼 | 歷史 |
| COAGHemab Therapeutics Holdings, Inc. | COM SHS | 3,602,093 | $1.32 億 | 1.9% | +3,602,093 | 新進 | 歷史 |
| TNGXTango Therapeutics, Inc. | COM | 4,200,000 | $1.31 億 | 1.9% | +1,450,000+52.7% | 加碼 | 歷史 |
| DFTXDefinium Therapeutics, Inc. | COM SHS | 2,750,000 | $1.29 億 | 1.9% | −250,000−8.3% | 減碼 | 歷史 |
| GRALGRAIL, Inc. | COM | 1,834,944 | $1.25 億 | 1.8% | +112,147+6.5% | 加碼 | 歷史 |
| BCAXBicara Therapeutics Inc. | COM | 4,100,000 | $1.22 億 | 1.8% | +37,500+0.9% | 加碼 | 歷史 |
| MAZEMaze Therapeutics, Inc. | COM | 3,732,569 | $1.11 億 | 1.6% | +255,007+7.3% | 加碼 | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 2,939,151 | $1.09 億 | 1.6% | +1,655,172+128.9% | 加碼 | 歷史 |
| LBRXLB Pharmaceuticals Inc | COM SHS | 3,352,804 | $1.09 億 | 1.6% | 00.0% | 不變 | 歷史 |
| MBXMBX Biosciences, Inc. | COM | 1,732,569 | $9,564 萬 | 1.4% | −1,025,000−37.2% | 減碼 | 歷史 |
| GHRSGH Research PLC | ORDINARY SHARES | 3,333,334 | $8,960 萬 | 1.3% | +3,333,334 | 新進 | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 2,000,000 | $7,740 萬 | 1.1% | +1,000,000+100.0% | 加碼 | 歷史 |
| ATAIAtaiBeckley Inc. | COM SHS | 14,417,442 | $7,598 萬 | 1.1% | +2,417,442+20.1% | 加碼 | 歷史 |
| UTHRUnited Therapeutics Corp | COM | 123,616 | $6,698 萬 | 1.0% | +123,616 | 新進 | 歷史 |
| AVTXAvalo Therapeutics, Inc. | COM NEW | 3,610,000 | $6,671 萬 | 1.0% | +3,610,000 | 新進 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 3,592,740 | $6,600 萬 | 1.0% | +2,198,796+157.7% | 加碼 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 700,000 | $5,963 萬 | 0.9% | −674,320−49.1% | 減碼 | 歷史 |
| ALTAltimmune, Inc. | COM NEW | 19,250,000 | $5,852 萬 | 0.9% | +19,250,000 | 新進 | 歷史 |
| PSNLPersonalis, Inc. | COM | 4,000,000 | $5,360 萬 | 0.8% | +1,000,000+33.3% | 加碼 | 歷史 |
| ACRSAclaris Therapeutics, Inc. | COM | 9,345,000 | $4,944 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| CRMDCorMedix Inc. | COM | 6,274,076 | $4,925 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| WGSGeneDx Holdings Corp. | COM CL A | 700,000 | $4,806 萬 | 0.7% | +700,000 | 新進 | 歷史 |
| HROWHarrow, Inc. | COM | 969,000 | $4,115 萬 | 0.6% | +969,000 | 新進 | 歷史 |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 2,491,939 | $3,723 萬 | 0.5% | +4000.0% | 加碼 | 歷史 |
| SLDBSolid Biosciences Inc. | COM NEW | 3,565,062 | $3,561 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| BEAMBeam Therapeutics Inc. | COM | 1,000,000 | $3,432 萬 | 0.5% | +179,235+21.8% | 加碼 | 歷史 |
| DYNDyne Therapeutics, Inc. | COM | 1,500,000 | $3,332 萬 | 0.5% | −500,000−25.0% | 減碼 | 歷史 |
| IMMXImmix Biopharma, Inc. | COM | 2,775,000 | $2,861 萬 | 0.4% | +2,775,000 | 新進 | 歷史 |
| XFORX4 Pharmaceuticals, Inc | COM NEW | 5,878,757 | $2,745 萬 | 0.4% | −460,778−7.3% | 減碼 | 歷史 |
| STTKShattuck Labs, Inc. | COM | 3,706,734 | $2,572 萬 | 0.4% | +3,706,734 | 新進 | 歷史 |
| MNKDMannkind Corp | COM NEW | 6,000,000 | $2,556 萬 | 0.4% | +6,000,000 | 新進 | 歷史 |
| IPSCCentury Therapeutics, Inc. | COM | 9,462,645 | $2,318 萬 | 0.3% | −25,100−0.3% | 減碼 | 歷史 |
| GENBGenerate Biomedicines, Inc. | COM SHS | 1,333,815 | $2,250 萬 | 0.3% | +1,333,815 | 新進 | 歷史 |
| VSTMVerastem, Inc. | COM NEW | 5,740,850 | $2,193 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| KURAKura Oncology, Inc. | COM | 1,978,565 | $2,170 萬 | 0.3% | −664,977−25.2% | 減碼 | 歷史 |
| ENTAEnanta Pharmaceuticals Inc | COM | 1,444,167 | $2,106 萬 | 0.3% | −512,700−26.2% | 減碼 | 歷史 |
| NKTRNektar Therapeutics | COM NEW | 300,000 | $2,094 萬 | 0.3% | +300,000 | 新進 | 歷史 |
| OLMAOlema Pharmaceuticals, Inc. | COM | 1,500,000 | $1,877 萬 | 0.3% | +1,500,000 | 新進 | 歷史 |
| KLRAKailera Therapeutics, Inc. | COMMON STOCK | 700,000 | $1,542 萬 | 0.2% | +700,000 | 新進 | 歷史 |
| KARDKardigan, Inc. | COM | 600,000 | $1,431 萬 | 0.2% | +600,000 | 新進 | 歷史 |
| ELVNEnliven Therapeutics, Inc. | COM | 225,000 | $1,142 萬 | 0.2% | +225,000 | 新進 | 歷史 |
| PMNProMIS Neurosciences Inc. | COM SHS | 835,655 | $1,100 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| IMCRImmunocore Holdings plc | ADS | 311,218 | $988.1 萬 | 0.1% | −1,620,666−83.9% | 減碼 | 歷史 |
| XNCRXencor Inc | COM | 593,551 | $955.6 萬 | 0.1% | +593,551 | 新進 | 歷史 |
| CNTXContext Therapeutics Inc. | COM | 7,419,355 | $411.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| IVAInventiva S.A. | ADS | 800,000 | $302.4 萬 | <0.1% | −422,453−34.6% | 減碼 | 歷史 |
| ALGSAligos Therapeutics, Inc. | COM NEW | 444,110 | $256.3 萬 | <0.1% | 00.0% | 不變 | 歷史 |
選擇權（1 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| GMABGenmab A/S | SPONSORED ADS | – | $8,241 萬 |
2026 年第 1 季之後清倉（14 檔）
2026 年第 1 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2026 年第 1 季股數 | 2026 年第 1 季市值 | 2026 年第 1 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| APLSApellis Pharmaceuticals, Inc. | COM | 4,532,374 | $1.82 億 | 3.8% | 歷史 |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 3,158,041 | $1.25 億 | 2.6% | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 841,445 | $6,249 萬 | 1.3% | 歷史 |
| TERNTerns Pharmaceuticals, Inc. | COM | 1,073,877 | $5,661 萬 | 1.2% | 歷史 |
| GERNGeron Corp | COM | 31,720,278 | $4,726 萬 | 1.0% | 歷史 |
| ANIPAni Pharmaceuticals Inc | COM | 600,000 | $4,614 萬 | 1.0% | 歷史 |
| SLNOSoleno Therapeutics Inc | COM | 1,078,710 | $3,612 萬 | 0.7% | 歷史 |
| ENGNenGene Therapeutics Inc. | COM | 4,377,572 | $2,981 萬 | 0.6% | 歷史 |
| APGEApogee Therapeutics, Inc. | COM | 285,000 | $2,399 萬 | 0.5% | 歷史 |
| JANXJanux Therapeutics, Inc. | COM | 1,187,290 | $1,650 萬 | 0.3% | 歷史 |
| CBIOCrescent Biopharma, Inc. | COM | 453,686 | $833.4 萬 | 0.2% | 歷史 |
| LRMRLarimar Therapeutics, Inc. | COM | 1,500,000 | $675.0 萬 | 0.1% | 歷史 |
| HELPCybin Inc. | COM NEW | 1,313,137 | $630.3 萬 | 0.1% | 歷史 |
| BLLNBillionToOne, Inc. | CL A | 50,000 | $394.7 萬 | 0.1% | 歷史 |